Our study is a proof of principle that inhibition of p110δ can favorably sway the balance between GvHD and GvL in a model of a strong acute GvHD and a highly aggressive tumor during fully MHC-mismatched hematopoietic cell transplantation. Here, PIK3CD is linked to graft versus host disease.